Transcript Highlights:

• <00:05:12.320> use both mental health and substance use both mental health and substance use
• They have oversight and work directly with process control champions to support the internal controls
• They have oversight and work directly with process control champions to support the internal controls
• Medicaid fraud control unit.
• Medicaid fraud control unit.

Keywords: 1183, house

Transcript Highlights:

• > drug on controlled substances in our drug on controlled substances in our drug supply<02:20:11.720
• A bill to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances
• into schedule one of the substances into schedule one of the Controlled<02:35:40.319> Substances<
• so law Controlled Substances Act so law enforcement<02:35:42.520> can<02:35:42.720> crack<
• Third reading to amend the Controlled Substances Act with respect to the scheduling of FAL-related substances

Keywords: U.S. House of Representatives Floor Proceedings on Thursday, February 6, 2025, 1012, house, all

Transcript Highlights:

• <00:12:52.079> substance<00:12:52.639> or<00:12:53.560> um up with a new controlled
• substance or um up with a new controlled substance or um uh<00:12:54.760> you<00:12:54.880>
• > we controlled substance and driving we controlled substance and driving we should<00:13:10.639>
• What is coercive control?
• It's because of coercive control.

Keywords: Meeting Start: 00:00:00 Roll Call: 00:00:02 HB 446: 00:01:44 HB 456: 00:07:08 Discussion in Opposition to HB 456: 00:15:20 HB 10: 00:26:18 HB 96: 00:36:54 HB 399: 00:56:31 HB 465: 01:03:04, 958, all

Summary: The committee met with a quorum and first took up House Bill 446, as amended by committee substitute, which would expand third-degree assault protections to cover judges and justices of the Court of Justice and public transportation drivers. Supporters said the bill responds to violence and threats against judges and would extend protections already given to other public servants. Members generally supported the bill, though several suggested broadening it further to include circuit clerks or all officers of the court. The committee adopted the substitute and favorably passed HB 446 on an 18-0 vote. The committee then considered House Bill 456, a DUI-related cleanup bill sponsored by Representative Patrick Flanery and presented by County Attorney Joe Ross. The bill would add fentanyl, Flexeril, and clopene to the per se DUI list, treat driving on a suspended license as an aggravating circumstance, revise implied-consent notice language, and make changes to ignition interlock rules, including suspension periods and fees. Representative Scott West of the Kentucky Association of Criminal Defense Lawyers testified in opposition, warning that some interlock violations and fees could unfairly extend suspensions and discourage participation, while members and the sponsor said the bill would strengthen DUI enforcement and that non-listed substances could still support DUI charges under other provisions. The committee adopted the substitute and favorably passed HB 456 by a 16-0 vote with one pass. Finally, the committee began hearing House Bill 10, relating to the rights of real property owners, sponsored by Representatives Maryanne Proctor and Emily Callaway, with testimony from a Pacific Legal Foundation representative and a Boone County Sheriff’s Office staff attorney. The sponsors said the bill is intended to address squatting by defining squatters and improving property-owner remedies, and noted support from sheriffs and realtors. The transcript cuts off before the bill’s full presentation or any committee action on HB 10.

Transcript Highlights:

• It is a controlled substance.
• They are controlled substances under the DEA Act.
• McGee: To be clear, marijuana is still a controlled substance federally and statewide. Right.
• I'm here to oppose destroying or banning controlled substances at compliant THC delivery systems.
• It would have put it on our controlled substance list or something similar.

Bills: SB 5, SB 11, SB 12

Keywords: disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, human trafficking, trafficking victim, compelling prostitution, affirmative defense, criminal defense, coercion, force fraud or coercion, sexual exploitation, victim protection, Penal Code, Texas criminal law, prosecution, party liability, affirmative defense statute, survivor rights

Summary: The Senate Committee on State Affairs took up Senate Bill 5, which Senator Perry described as a ban on intoxicating THC consumer products while preserving legal CBD, CBG, hemp seed, hemp seed protein powder, and hemp seed oil products. Perry argued that most retail THC products are already illegal under federal law, that the industry has used loopholes and misleading labeling to sell high-potency products, and that regulation would be ineffective because chemists can quickly alter formulations. He also said the bill would steer people with medical needs toward the Texas Compassionate Use Program (T-Cup), which he and other supporters described as the proper physician-guided alternative. Committee members and witnesses repeatedly discussed the distinction between legal hemp-derived products and intoxicating THC products, and Perry said the bill would not touch non-consumable hemp uses such as fiber and clothing. Invited testimony came from law enforcement and medical witnesses who supported the bill. Texas Police Chiefs Association representative Steve Dye, Kaufman County District Attorney Early Wiley, and Chambers County Sheriff Brian Hawthorne all said regulation would be too costly, too complex, and ultimately unenforceable, while a ban would be clearer and easier to enforce. They cited overloaded DPS labs, the need for expensive private testing, limited police and prosecutor resources, and the difficulty of keeping up with constantly changing cannabinoids and out-of-state products. Hawthorne and Wiley described raids and investigations involving warehouses, retail stores, cash seizures, and products they said were marketed to young people and often mislabeled or imported from other states. They also said the bill would help law enforcement by creating a clearer legal line and protecting legitimate CBD/CBG businesses. Dr. Lindy McGee, speaking for the Texas Medical Association and Texas Pediatric Society, testified that retail THC products pose serious risks to children and adolescents, including addiction, impaired brain development, psychosis, suicide attempts, self-harm, accidental toddler ingestions, and possible long-term cognitive effects. She said there is no effective medication treatment for THC addiction comparable to nicotine cessation tools, and she supported restrictions such as child-resistant packaging, no marketing to minors, and age limits, while opposing criminal penalties for possession by minors. Senators asked follow-up questions about brain development, memory, dementia risk, pregnancy, and cardiovascular effects. No vote was taken during the portion provided, and the committee continued with invited testimony and questions.

Transcript Highlights:

• Substance Act.
• Um, so this is for Senate Bill 1452, Senate Draft 1, House Draft 2, relating to the Uniform Controlled
• Substance Act.
• Again, this is the Uniform Controlled Substance Act, Federal Controlled Substances Act.
• Again, this is the Uniform Controlled Substance Act, Federal Controlled Substances Act.

Keywords: 912, senate, all

Summary: The joint House and Senate conference committee met on April 17, 2025, and discussed three measures. For SB 88 HD1, relating to the Hawaii National Guard, and SB 1377 SD2 HD1, relating to veteran cemeteries, conferees said proposed conference drafts had been circulated, but both bills still needed WHAM and Finance approval and an effective-date adjustment, so each was rolled over to Monday, April 21, 2025, at 1:30 p.m. in Conference Room 16. For HB 433 HD1 SD1, relating to public safety and re-entry services, members said they were waiting for the budget to close. The Senate indicated it was agreeable to a reporting addition in the Senate draft, and staff would circulate alternate drafts depending on whether an appropriation was included in the final budget. That bill was also held over to April 21 at 1:30 p.m. At the 3:30 p.m. conference, the committee took up SB 1452 SD1 HD2, relating to the Uniform Controlled Substance Act. Conferees agreed to the House version with an effective date of July 1, 2025, and noted no WHAM or Finance referral was needed. The committee then voted unanimously to adopt the proposed conference draft, with Senate and House conferees all voting aye except one excused Senate member, and the bill was reported out successfully.

Transcript Highlights:

• Two, whether xylazine should be classified as a controlled substance and appropriate penalties for its
• Two, whether zylozine should be classified as a controlled substance and appropriate penalties for its
• I'm actually, I know that our charge is to do something around classifying it as a controlled substance
• The second one is about classifying it as a controlled substance.
• The second one is about classifying it as a controlled substance.

Keywords: 995, all

Summary: The Special Commission on xylazine held its first meeting, with House Chair Mindy Domb and Senate Co-Chair John Keenan outlining the commission’s charge and a proposed work plan. The commission is tasked with studying the public health and safety impacts of xylazine in the illicit drug supply, including whether it should be scheduled as a controlled substance, how to regulate its production and distribution, and how to improve outreach and treatment for people exposed to it. Members were told the report deadline had been extended to March 30, 2026, and staff proposed a series of public hearings and working groups leading to a final report. The meeting also included attendance, packet materials, and procedural planning. The first major testimony came from BSAS Director Deirdre Calvert, who described xylazine’s appearance in Massachusetts drug supply data, the state’s public health alerts, and DPH’s partnership with Brandeis, CDC, and harm reduction organizations. She emphasized four priorities: reducing stigma and discrimination in health care, expanding self-directed wound care support and coverage for supplies, expanding access to drug checking and test strips, and supporting low-barrier services such as mobile vans and drop-in centers. Commission members asked about first responder awareness, medical education, and whether harm reduction services might face federal restrictions; Calvert said misinformation remains a problem and noted ongoing training efforts, including collaboration with public safety agencies. Several other speakers reinforced the need for low-barrier care and drug checking. Dr. Raghini Jala, an infectious disease and addiction medicine physician, said xylazine has become a common component of the unregulated opioid supply and urged support for rapid-response education teams, community-based drug checking, and better hospital and detox protocols for xylazine withdrawal and wounds. Recovery coach Alan Young testified from lived experience, describing severe wounds, fear of inadequate withdrawal treatment in emergency settings, and the value of mobile care vans that can provide methadone, buprenorphine, and wound care in the community. Dr. Sarah Wakeman echoed the need for naloxone, rescue breathing, low-threshold treatment, and non-stigmatizing health care settings, while Sarah Macon of the Boston Public Health Commission described Boston’s harm reduction and drug checking work, including on-site testing, wound care, and a decline in opioid mortality. Tracy Green of the Massachusetts Drug Supply Data Stream explained that xylazine has declined in recent samples while metatomidine is rising, said drug checking is increasingly used but still not enough, and argued for more funding, staffing, and statewide access to real-time drug checking and harm reduction services.

Transcript Highlights:

• Substance Board.
• under the Controlled Substances Act.
• Most of our state's laws are tied to the Controlled Substances Act.
• It's a legal substance. I was on the Controlled Substance Board in Wisconsin in 2015.
• as Schedule 1. ...Schedule 1 under the Controlled Substances Act.

Transcript Highlights:

• Substances Act, which caused... ...an omnibus farm bill with amendments to the Controlled Substances
• substance under federal law.
• Substances Act.
• I treat a variety of substance use disorders, and cannabis is by far the most misused substance by teens
• Alcohol substance abuse disorder.

Keywords: 995, all

Summary: The Joint Committee on Cannabis Policy held a hearing on a broad set of cannabis and hemp bills, with the chairs opening by emphasizing unfinished work on equity, public health, safety, and market stability. The committee heard testimony on House Bill 146, which would create more efficient cannabis testing standards by increasing batch sizes, reducing or eliminating some environmental testing, standardizing lab reporting, and requiring annual scientific review and public data reporting. Industry witnesses, including a representative of the Massachusetts Cannabis Coalition, cultivators, and a testing lab owner, said current testing rules are overly burdensome, costly, and inconsistent, and argued the bill would lower compliance costs while preserving consumer safety. A testing lab witness also said some operators switch labs to obtain higher THC results or pass contaminated batches, and urged greater transparency and better sampling protocols. A major portion of the hearing focused on intoxicating hemp and related bills that would bring hemp-derived intoxicating products under a stronger regulatory framework. Legislators and industry witnesses described products sold in gas stations, smoke shops, and convenience stores as often untested, not age-gated, and sometimes mislabeled or far above the federal hemp THC threshold. Testimony from attorneys and cannabis business leaders said states can regulate these products more strictly under the Farm Bill’s non-preemption language, and pointed to New Jersey and other states as possible models. Some witnesses and committee members stressed that any new rules should avoid harming non-intoxicating CBD businesses or lawful hemp farmers, while others argued that the products are effectively cannabis and should be regulated like cannabis for licensing, testing, age limits, and taxation. The committee also heard extensive public-health testimony in support of bills S. 95, S. 96, S. 97 and their House counterparts H. 191, H. 192, and H. 193. Parents, advocates, and public health professionals urged stronger warning labels, THC potency caps, and improved data collection on cannabis-related harms, citing cannabis-induced psychosis, addiction, anxiety, and youth exposure to high-potency products. Several witnesses said Massachusetts has not done enough to track health outcomes or warn consumers, and referenced other jurisdictions such as Connecticut, Vermont, Colorado, Canada, and Quebec as examples of stronger limits or warnings. No votes or formal actions were taken during the hearing; the committee primarily received testimony and questions.

Transcript Highlights:

• To help deal with all the controlled substances that people are driving under and the different types
• Apologies, but HB 106 treats cannabis like alcohol and controlled substances, including blood tests,
• , which will cover all substances, all controlled substances.
• That's why we feel it should be controlled substances, drugs, or other potentially impairing substances
• I think there are legal issues that need to be dealt with, but we would be to put controlled substances

Transcript Highlights:

• This is the public hearing for Mental Health, Substance Use and Recovery, and we're going to be talking
• At five years in recovery, they were sending me to go have a substance use evaluation.
• Having recurring or quarterly trainings with professionals in the field of substance use disorder and
• And that was out of control in this hospital environment as well.
• And that was out of control in this hospital environment as well.

Keywords: 995, all

Summary: The committee held a public hearing on a broad set of mental health, substance use, recovery, and patients’ rights bills. Early testimony focused on H. 2227, which would replace stigmatizing substance use terminology in the General Laws, and H. 3950, which would support parents in recovery involved with DCF by requiring more individualized recovery plans, clearer benchmarks for parenting time, access to recovery coaches or counselors, family counseling after sustained recovery, and staff training on addiction and lived experience. Speakers described the bills as ways to reduce stigma, increase accountability, and improve reunification outcomes for families. A major portion of the hearing centered on S. 1386, which would transfer Bridgewater State Hospital from the Department of Correction to the Department of Mental Health. Advocates, family members, and disability groups testified that Bridgewater functions like a prison rather than a hospital, with excessive restraint, seclusion, involuntary medication, poor conditions, and racial disparities, and argued DMH should oversee a treatment setting. One DMH occupational therapist and MNA member opposed the transfer, saying the real issue is mixing forensic and continuing-care patients and that DMH should instead create designated forensic units under bills H. 228/S. 1408. Committee members asked about Bridgewater’s population, the history of DOC control, capacity, staffing, and how a transfer might be implemented. The committee also heard testimony on modernizing the six fundamental rights for psychiatric inpatients, including expanding communication options, clarifying visitation and advocacy definitions, and improving access to gender-appropriate and culturally relevant items. Another bill, H. 2216, would require stronger oversight before antipsychotic medication is prescribed in nursing homes, prompted by concerns about inappropriate use. Finally, testimony supported H. 2240 and H. 2239 on sober homes, with supporters saying discharge and relocation policies are needed when a resident returns to active use or becomes unsafe, while preserving the recovery environment and resident rights. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• Substance abuse treatment records are covered by 42 CFR Part 2.
• The patient controls how the records can be used and disclosed.
• So the toxicology results will run a panel across illegal substances.
• or illegal substance, but that specific medication It may not be a controlled or an illegal substance
• substances, but also other— The 893 controlled substances, but also other—I mean, it's a much more medical

Summary: The committee convened with a quorum present and heard a presentation from FDLE Deputy Commissioner Vaden Pollard on homicide investigations, blood evidence, toxicology, medical records, and mental health records. Pollard explained that autopsy toxicology and medical examiner records are often critical in death investigations, but access to hospital blood tests, medical records, Baker Act records, and substance abuse treatment records is restricted by Florida law, HIPAA, and 42 CFR Part 2, usually requiring subpoenas, court orders, or consent. He also noted that autopsy reports are generally public, while photographs are confidential, and that medical examiners can access relevant prior medical history of decedents. Members questioned Pollard about what toxicology panels include, whether medications can be tested for, and whether medical examiner reviews can help determine if a deceased person had stopped taking prescribed psychiatric medication. Pollard said toxicology can include alcohol, drugs, and specific medications when relevant, but routine access to living suspects’ medical information is limited. He also discussed FDLE’s behavioral threat assessment work and said investigators may follow leads involving mental health treatment or facility releases when relevant to a case, though he could not speak to regulatory follow-up. The committee also discussed risk protection orders, with Pollard saying FDLE has used them effectively and that they can help prevent violence and connect individuals to services. The discussion then shifted to FDLE laboratory turnaround times and public safety impacts. Pollard said the average DNA turnaround time was 208 days for some cases, while sex assault kits are prioritized and generally remain under 90 days, with rush cases sometimes completed within 24 hours. He said backlog is tied to staffing and analyst capacity, and that faster processing is especially important in unsolved violent and sexual assault cases because delays can leave offenders on the street. The committee also noted that increased toxicology demands would affect toxicology staffing and workload, though not DNA processing. No votes were taken, and the meeting adjourned after the presentation and questions.

Transcript Highlights:

• We're taking up tab 3 now with Senator Yarbrough, going over to SB 432 on controlled substances by Senator
• substances.
• Second, the bill amends Section 893 to exempt from the list of Schedule I controlled substances zylazine
• that impacts our brain and our behavior and leads to the inability to control our use of substance, legal
• It's going to set me off, and I'm going to lose control.

Summary: The Appropriations Committee on Criminal and Civil Justice heard and approved several bills. SB 504 and its related public records bill SB 506, both by Sen. Burgess, would allow local governments to authorize code enforcement officers to use body cameras under standardized policies and create a public records exemption for certain recordings; members raised questions about disclosure and when cameras may be used, and both bills were reported favorably. The committee also approved CS/SB 32 and SB 210 by Sen. Sharif, creating a new injunction for protection against serious violence by a known person and extending public records protections to petitions under that injunction category. Supporters included law enforcement, women’s advocacy groups, and justice organizations. The committee then favorably reported SB 676 by Sen. Arrington, which creates a graduated penalty structure for adults who involve minors in certain animal cruelty offenses and increases penalties related to fighting or baiting animals. SB 432 by Sen. Yarbrough was also approved; it adds certain concentrated 7-OH to Schedule I, exempts FDA-approved veterinary xylazine products, creates penalties for candy-like xylazine products, and establishes trafficking penalties for xylazine. Sen. Osgood spoke in support of the bill, emphasizing the dangers of adulterated street drugs for people with substance use disorder. Finally, the committee approved SB 524 by Sen. Simon, which makes a series of technical and administrative changes affecting the Medical Examiners Commission, district medical examiner appointments, the Criminal Justice Standards and Training Commission, and notice procedures for administrative complaints. The Florida Department of Law Enforcement appeared in support. All measures were reported favorably, and the committee adjourned without objection.

Transcript Highlights:

• Yarbrough, going over to tab 3, SB 432 on controlled substances by Senator Yarbrough.
• substances.
• Second, the bill amends Section 893 to except from the list of Schedule I controlled substances xylazine
• that impacts our brain and our behavior and leads to the inability to control our use of substance, legal
• It's going to set me off, and I'm going to lose control.

Bills: S0032, S0210, S0432, S0504, S0506, S0524, S0676

Keywords: injunctions, protection orders, domestic violence, serious violence, court procedures, enforcement, risk protection, statewide communication system, public records, violence protection, confidentiality, defamation, code inspector, code enforcement, body camera, body-worn camera, police body cam, municipal code enforcement, local government, video recording

Summary: The Appropriations Committee on Criminal and Civil Justice met with a quorum present and considered several bills. The committee heard and approved SB 504, allowing local governments to adopt standardized policies for code enforcement officers to use body cameras, and SB 506, which creates a related public records exemption for certain body camera recordings, including protections for minors and private information. Senator Smith raised questions about notice to property owners and use limitations, and Senator Osgood asked whether cameras must be on at all times; the sponsor said he would follow up on specifics. Both bills had support from local government and code enforcement groups and were reported favorably after adoption of an amendment to SB 504 clarifying training and familiarity with camera rules. The committee also approved CS/SB 32, creating a new injunction for protection against serious violence by a known person, and SB 210, the companion public records exemption for petitions involving that injunction. Senator Sharif said the bills fill a gap for victims who do not qualify under existing injunction categories, and supporters waived in favor. SB 676, by Senator Arrington, was also reported favorably; it creates a graduated penalty structure for contributing to the delinquency of a minor when the underlying conduct involves certain animal cruelty offenses, and increases penalties for fighting or baiting animals. Senator Osgood spoke in support, tying the bill to protecting children and animals, and several law enforcement and animal welfare groups waived in support. The committee further approved SB 432, which adds certain concentrated 7-OH to Schedule I, exempts FDA-approved veterinary xylazine products, creates a first-degree felony with a mandatory minimum for certain candy-like xylazine products, and establishes trafficking penalties for xylazine. Senator Osgood spoke at length in support, emphasizing overdose risks and the impact on people with substance use disorder. Finally, the committee passed SB 524, which revises duties and appointments related to the Medical Examiners Commission and district medical examiners, clarifies responsibilities within Chapter 943, and changes notification and curriculum approval provisions for criminal justice standards. All measures were reported favorably, and the committee adjourned without objection.

Transcript Highlights:

• We do not perform surgery, treat emergencies, carry controlled substances, or house animals overnight
• substances, or house carry controlled substances, or house animals<00:09:02.640> overnight.
• If that vet wrote a prescription to one person for a controlled substance, then that would have to be
• If that vet wrote a prescription to one person for a controlled substance, then that would have to be
• If that vet wrote a prescription to one person for a controlled substance, then that would have to be

Keywords: 958, all

Summary: The committee first reviewed several Fish and Wildlife regulations. Staff explained amendments to 301 KAR 2:176, 4:112, and 6:030, including updating wildlife control tag language, creating an impoundment agent program for seized wildlife, and clarifying boating safety rules. A member raised a concern about boat wakes near docks, and staff said the commission had recently voted on related changes that were not yet included because the regulation had been filed earlier; those changes would have to come back later. The committee approved the staff amendments without objection. The Board of Veterinary Examiners then presented 201 KAR 16:767, which would require veterinary managers to be physically present during business hours and limit them to five registered facilities. Board representatives said they had tried to meet with affected parties before the hearing but had not reached agreement. A representative for Kentucky Pet IQ argued the rule was written for full-service hospitals and would be impractical for short, limited-service clinics that only provide vaccinations, preventive care, and parasite testing. Members expressed concern about the rule’s impact on veterinary access in underserved areas, and the committee voted to defer the regulation until the next month so the parties could continue negotiating. The committee next considered Transportation Cabinet 601 KAR 9:120, the online insurance verification system, in both ordinary and emergency form. The chair said staff had identified conflicts with a bill passed the prior year and moved to find the regulations deficient. The motion passed on a roll call vote, with six ayes and two pass votes. The committee then found ordinary ABC regulations 804 KAR 12:020 and 12:030 deficient as well, again by six ayes and two pass votes, after noting that the emergency versions had already been found deficient the previous month. Finally, the committee reviewed Cabinet for Health and Family Services 902 KAR 55:110, which would require veterinarians to report dispensed controlled substances to KASPER while exempting administered medications. OIG staff said the rule was meant to align regulation with statute, which includes veterinarians as prescribers, and emphasized that the reporting duty applies to prescriptions, not administration to animals. Some members supported the change as a needed anti-diversion measure, while others worried about implementation burdens and timing. After discussion, the committee found the regulation deficient by a 6-2 vote. The meeting then moved into full review of 922 KAR 1:565, a Department for Community Based Services rule implementing kinship care provisions from Senate Bill 151; staff said it was needed for implementation once funding is available, but a member criticized the two-year delay and the inclusion of language conditioning implementation on funding. A public witness from the Kinship Families Coalition argued the rule should not shift the 120-day application window in a way that could affect federal funding eligibility and urged the committee to reject the regulation as written.

Transcript Highlights:

• It's behavioral health and substance use disorder.
• It's a perfect analogy for substance use disorder.
• Substance use disorders are no different than that.
• Historically, we've treated substance use as someone uses substances or they don't use substances, and
• It's a controlled substance.

Keywords: 959, house, all

Transcript Highlights:

• substances, often in a so-called meth lab.
• This legislation clearly defines distribution of Class A controlled substances or counterfeit controlled
• More often than not, those who buy these substances are victims of substance use disorder, chronically
• The individuals targeted by this legislation are distributing a Class A controlled substance, which is
• often counterfeit substances like fentanyl, but peddled as a different substance to achieve greater

Keywords: 995, all

Summary: The hearing covered a wide range of Judiciary Committee bills, with much of the testimony focused on criminal justice, public safety, and civil asset forfeiture reform. Several lawmakers and advocates supported bills to increase penalties or create new offenses related to assaults on sports officials, assaults on transit workers, reckless discharge of firearms, fires and explosives, pill press machines, and drug-induced homicide. Testifiers described rising harassment and violence against youth sports officials and transit workers, as well as the fentanyl overdose crisis and the need for stronger tools to prosecute dealers whose conduct leads to death. Supporters of the sports-official and transit-worker bills emphasized declining referee availability and repeated assaults on commuter rail and MBTA workers. District attorneys also backed bills on reckless firearm discharge and fires/explosives, saying current law does not adequately address dangerous conduct that endangers bystanders. The committee also heard testimony on several proposals related to youth diversion and prison mitigation. Supporters of the youth court justice fund bill said youth courts are peer-led diversion programs with strong compliance and low recidivism, and argued for a stable funding source rather than annual earmarks. A representative from Bridgewater supported a prison mitigation fund for municipalities that host state prisons, saying the costs of public safety and emergency services are not fully covered. On gun policy, testimony split between supporters of a bill to ban in-state manufacture of assault-style rifles for civilian sale and opponents or skeptics of other firearm-related measures, including a bill on collateralizing firearms and a bill to increase penalties for drug trafficking combined with illegal firearm offenses. A major portion of the hearing was devoted to civil asset forfeiture reform. Advocates from the ACLU, CPCS, the Boston Bar Association, the Institute for Justice, and others supported bills to increase the burden of proof, improve transparency and reporting, require counsel, and limit or eliminate the current practice of directing forfeiture proceeds to law enforcement. They argued the current system creates perverse incentives, lacks adequate due process, and is insufficiently transparent. District Attorney Paul Tucker defended current forfeiture practices, saying his office has reporting and oversight, uses the funds for investigations and community programs, and warned that reducing forfeiture revenue would hinder crime fighting. No votes or final committee actions were taken during the hearing; the chairs repeatedly thanked witnesses and indicated the bills would remain under consideration.

Transcript Highlights:

• constitutional officers are in control constitutional officers are in control of<00:03:59.120>
• substances that are per se DUI.
• Line eight we've added a substance. And line 10 we've added a substance.
• Most importantly, fentanyl is the substance we've added that is a per se substance now.
• per<00:15:45.040> se controlled substances that are per se controlled substances that are

Keywords: 958, all

Summary: The Senate Judiciary Committee heard and advanced several bills. Senate Bill 198, relating to operations of the Office of the Attorney General, was described as a cleanup measure with seven changes, including allowing the AG’s office to handle child support employee background checks and fingerprinting, updating child support guideline commission references, clarifying control of constitutional officers’ records in multistate litigation, setting a 10-year statute of limitations for certain consumer protection matters, streamlining administrative hearing appeals, and changing representation of the professional geologist board. After questions about the administrative hearing appeal language, the committee passed the bill 9-0. The committee then passed Senate Bill 323, which would require subpoenas for medical records to be served at least 14 days before production. President Stivers said the bill is intended to give health care providers reasonable time to comply with HIPAA, redact records, and avoid motions to quash when subpoenas are served on short notice. A question about appeal deadlines was answered by noting the bill would not affect the common 10-day motion-to-reconsider rule. The bill passed 9-0. Senate Bill 66, as amended by committee substitute, was also passed 9-0. The substitute addressed DUI-related issues, including preserving certain driving records for 10 years, removing urine screens from the bill, adding fentanyl and other substances to the per se controlled-substances DUI list, and clarifying that a preliminary breath test may be refused and that officers should advise drivers of that right. The committee also passed Senate Bill 221, a model-law bill making the knowing purchase, sale, transfer, or offer to sell human remains for consideration a Class D felony; members asked about whether it could affect older medical specimens or fetal remains, and sponsors said the bill is aimed at remains authorized for final disposition through cremation or burial. That bill passed 8-0. Finally, Senate Bill 312, concerning court-ordered transports in mental health cases, was presented by court security and sheriff’s association representatives. They said the bill clarifies that sheriffs may use court security staff to monitor and transport individuals undergoing 202A mental health evaluations, addressing staffing shortages and existing practice. The committee passed the bill 8-0. The committee then began hearing Senate Bill 333 on body armor grants, with the Attorney General’s office testifying that the bill would transfer administration of the Law Enforcement Protection Program to the AG and align it with the office’s existing body armor grant program, but the transcript cuts off before any vote on that measure.

Transcript Highlights:

• There is no crime if there is no controlled substance.
• Substance Act, One of the issues we've got with our Controlled Substance Act is that any concentrate
• And if these sorts of controls already exist at the federal controlled-substance level, right?
• That's what the Controlled Substances Act is.
• That's what the Controlled Substances Act is.

Summary: The House Committee on Public Health heard House Bill 5, a proposal to ban THC products outside the Texas Compassionate Use Program while allowing non-intoxicating CBD and CBG products under tighter regulation. Chair Van Deaver gave a lengthy background on the 2018 federal Farm Bill and Texas’s 2019 hemp law, arguing that the lack of guardrails allowed a large, unregulated THC market to develop. HB 5 would impose licensing fees, product registration, testing and inspection requirements, and restrictions intended to keep products away from children. Invited witnesses from law enforcement strongly supported the bill. Steve Dye of the Texas Police Chiefs Association and Brian Hawthorne of the Sheriffs’ Association of Texas argued that THC consumables are widely mislabeled, often far more potent than advertised, and linked to youth access, impaired driving, and organized crime. Both said regulation would be ineffective and would amount to legalization, while a ban would be easier for officers to enforce. They also emphasized support for the Texas Compassionate Use Program and said medical THC should remain available. Dr. Peter Stout of the Texas Association of Crime Lab Directors and Alice Amelot of Texas DPS testified as resource witnesses about forensic testing. They said current lab resources are already stretched thin, that quantitative testing for THC and related cannabinoids is expensive and time-consuming, and that a ban would simplify enforcement because labs could focus on presence/absence testing rather than concentration. Amelot said DPS labs are neutral on the bill but explained that mislabeled products and inaccurate certificates of analysis are common. Committee members asked about traffic safety, impairment, youth use, and the costs of enforcement and lab testing; witnesses repeatedly said the bill would reduce complexity for law enforcement but that any approach would still require more resources for labs.

Transcript Highlights:

• in an instance of suspected or actual criminal exposure to controlled substances.
• House Bill 473 offers a simple but critical fix, expanding the statute to cover all controlled substances
• So, so I'm looking at this bill has a exposing children to controlled substances.
• You know, the fact that it's exposing children to a controlled substance, if that's the case, then I
• I understand the fact that it's protected by the exposing of a controlled substance is my first factor

Keywords: 1191, senate, all

Transcript Highlights:

• Before this, there was methadone, and methadone is highly controlled, hard to get at, daily dosages when
• Before this, there was methadone, and methadone is highly controlled, hard to get at, daily dosages when
• It is a life or death bill for many people who are seeking substance use disorder treatment and don't
• Thank you. methadone is highly controlled, hard to get at, daily dosages when you got to get in a car
• "There's such a need for substance use treatment in this state and in this country.

Keywords: 1183, house

Summary: House File 4493 would authorize pharmacists to initiate, prescribe, administer, and dispense certain drugs for opioid use disorder, especially buprenorphine/Suboxone. Representative Baker said the bill is intended to save lives by giving people immediate access to treatment at the moment they seek help, rather than making them wait for a doctor’s appointment or navigate more cumbersome methadone access. He emphasized that pharmacists are widely accessible, including in greater Minnesota, and that optional training would support safe prescribing. Representative Bierman spoke in strong support, calling the measure a life-or-death step forward for people with substance use disorder and noting that many people do not receive treatment when they need it. He said he initially had concerns but Baker listened to his suggested changes and worked with him and bill drafters, which helped address those concerns. Bierman also referenced the ongoing fentanyl crisis and encouraged members to learn more from displays honoring overdose victims. Baker closed by sharing personal remarks about losing his son to addiction and describing how limited treatment options were at that time. He said the new federal change allowing pharmacist training makes the bill timely and urged members to support it. After discussion, the House took a roll call vote and passed the bill 134-0, with the title agreed to.